Tagged content

Biological Products

2 articles

Biosimilar Pharmacovigilance: The Importance of Traceability

Pharmacovigilance for Biosimilar Products: Navigating the Complexities of Traceability

The increasing availability of biosimilar medicinal products has transformed healthcare by expanding patient access to life-saving biological therapies while reducing treatment costs. Biosimilars are highly similar to an…

June 15, 2026

Egyptian Drug Authority Opens Public Consultation on Biological Products Registration Guideline

Important

Egyptian Drug Authority Announces Public Consultation on Draft Guideline for Biological Products Registration

On 10 February 2026, the Egyptian Drug Authority (EDA) announced the launch of a public consultation on a new draft regulatory guideline titled: Guideline for Content File of…

February 19, 2026

Ready to simplify your journey?

Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.

Request Free Consultation

Submit RFI/RFP

No commitment required · 48h response time